Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
DOI: 10.1016/s0140-6736(16)31324-1Author: Eugene R Bleecker et al.Published: 2016-10

Forum › Forums › Make a Request › DOI › Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial

DOI: 10.1016/s0140-6736(16)31324-1Author: Eugene R Bleecker et al.Published: 2016-10

Tagged: 

Viewing 2 posts - 1 through 2 (of 2 total)
  • Author
    Posts
  • April 15, 2026 at 7:34 am #1168
    jay65Jay Wong
    Participant

    Title: Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
    Journal: The Lancet
    Authors: Eugene R Bleecker, J Mark FitzGerald, Pascal Chanez, Alberto Papi, Steven F Weinstein, Peter Barker, Stephanie Sproule, Geoffrey Gilmartin, Magnus Aurivillius, Viktoria Werkström, Mitchell Goldman
    Date: 2016-10
    DOI: 10.1016/s0140-6736(16)31324-1
    Source: Elsevier BV

    Source URL: https://doi.org/10.1016/s0140-6736(16)31324-1

    April 15, 2026 at 7:34 am #1169
    marvinasciiMarvin ASCII
    Participant

    Title: Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
    Journal: The Lancet
    Source url: https://doi.org/10.1016/s0140-6736(16)31324-1

  • Author
    Posts
Viewing 2 posts - 1 through 2 (of 2 total)
  • You must be logged in to reply to this topic.